OncoCyte Corp Stock News

OncoCyte (OCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

OncoCyte (OCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

DetermaIO identifies responders to immunotherapy among the 95% of patients with colon cancer currently ineligible for treatment based on existing biomarker, addressing a significant unmet need

Upgrades Susquehanna upgraded the previous rating for Lattice Semiconductor Corp (NASDAQ:LSCC) from Neutral to Positive. In the first quarter, Lattice Semiconductor showed an EPS of $0.37, compared to

OncoCyte Corporation (NASDAQ:OCX ) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Ronnie Andrews – President and Chief Executive Officer Mitch Levine – Chief Financi

OncoCyte (OCX) delivered earnings and revenue surprises of 15.38% and 16.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OncoCyte (OCX) delivered earnings and revenue surprises of 15.38% and 16.18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Tivity Health (TVTY) delivered earnings and revenue surprises of -4.76% and 4.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

We circle back on OncoCyte Corp. for the first time in just over one year. This oncology diagnostic concern has several new products it plans to launch on the near-term horizon.

IRVINE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insight

IRVINE, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights

Data points to accuracy of IO Score and provides grounds for its further use to evaluate response to immune checkpoint therapies for patients with colorectal, gastric and breast cancers Data points to

Data points to accuracy of IO Score and provides grounds for its further use to evaluate response to immune checkpoint therapies for patients with colorectal, gastric and breast cancers Data points to

Gold futures traded lower this morning on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around

US crude oil futures traded lower on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the co